New York State Common Retirement Fund’s Exagen XGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-97
Closed -$1K 3466
2022
Q2
$1K Sell
97
-6,800
-99% -$39.6K ﹤0.01% 3422
2022
Q1
$55K Hold
6,897
﹤0.01% 3149
2021
Q4
$80K Sell
6,897
-26
-0.4% -$305 ﹤0.01% 3137
2021
Q3
$94K Sell
6,923
-4,016
-37% -$53.4K ﹤0.01% 3161
2021
Q2
$164K Buy
10,939
+6,339
+138% +$97.2K ﹤0.01% 3107
2021
Q1
$81K Hold
4,600
﹤0.01% 3122
2020
Q4
$61K Hold
4,600
﹤0.01% 3161
2020
Q3
$50K Hold
4,600
﹤0.01% 3140
2020
Q2
$57K Hold
4,600
﹤0.01% 3140
2020
Q1
$73K Hold
4,600
﹤0.01% 2875
2019
Q4
$117K Buy
+4,600
New +$81.8K ﹤0.01% 2962

Other funds holding XGN

New York State Common Retirement Fund's XGN Position: Q3 2022 in Review

New York State Common Retirement Fund sold out of Exagen (XGN) in Q3 2022, closing a stake of 97 shares — an estimated $1K sold.

New York State Common Retirement Fund first reported a position in XGN in Q4 2019 and held it in 11 quarters. The position peaked at $164K in Q2 2021. 38 funds tracked by Wall St. Rank hold XGN as of Q3 2022.

  • New York State Common Retirement Fund reported no remaining Exagen position as of Q3 2022 after selling out during the quarter.
  • New York State Common Retirement Fund sold 97 Exagen shares in Q3 2022, an estimated $1K.
  • New York State Common Retirement Fund first reported a position in Exagen in Q4 2019 and held it in 11 quarters.
  • New York State Common Retirement Fund's Exagen position peaked at $164K in Q2 2021.
  • 38 funds tracked by Wall St. Rank held Exagen as of Q3 2022.

Based on New York State Common Retirement Fund's 13F filing for Q3 2022, filed 8 Nov 2022.